Abstract
Background
Poor adherence of acne patients to treatment may equate to poor clinical efficacy, increased healthcare costs, and unnecessary treatments. Authors have investigated risk factors for poor medical adherence and how to improve this difficult problem in the context of acne.
Objective
This systematic review aims to describe what methods have been used to measure adherence, what is known about acne patients’ adherence to treatment, and the factors affecting adherence.
Methods
A MEDLINE search was performed for randomized controlled trials published between 1978 and June 2013, focusing on patient adherence to prescribed acne medications. A test for equality of proportions was performed on studies of similar design to collectively analyze adherence to oral versus topical medication. The self-reported adherence data collected from these clinical trials were then compared with adherence data from a pharmacy database study.
Results
Studies varied in modalities of data collection, but the majority utilized subjective methods. Topical therapies were more often studied than oral. The overall oral adherence rate, as calculated by a test of equality of proportions, was 76.3 %, while the overall topical adherence rate was 75.8 % (p = 0.927). The occurrence of side effects and young age were cited as the top reasons for poor adherence, followed by forgetfulness.
Limitations
The MEDLINE search resulted in a limited sample of adherence studies. In addition, there is currently no standardized or fully validated method of measurement, allowing for variability in what was considered ‘adherent’. Lastly, data collected via subjective methods cannot guarantee reliable results.
Conclusions
Overall, the values reflected a population adherent to both topical and oral medications, with no significant difference in adherence between the two. However, the methodologies used by many of the studies were weak, and the findings are not consistent with results of more objective measures of adherence. The leading factors that contribute to poor adherence may be reduced with enhanced patient consultation, reminder systems, and education.
Similar content being viewed by others
References
Ellis RM, Koch LH, McGuire E, Williams JV. Potential barriers to adherence in pediatric dermatology. Pediatric Dermatol. 2011;28(3):242–4.
Dréno B, Thiboutot D, Gollnick H, Finlay AY, Layton A, Leyden JJ, Leutenegger E, Perez M. Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol. 2010;49(4):448–56.
McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288:2868–79.
Miyachi Y, Hayashi N, Furukawa F, Akamatsu H, Matsunaga K, Watanabe S, Kawashima M. Acne management in Japan: study of patient adherence. Dermatology (Basel, Switzerland). 2011;223(2):174–81.
Pawin H, Beylot C, Chivot M, Faure M, Poli F, Revuz J, Dréno B. Creation of a tool to assess adherence to treatments for acne. Dermatology (Basel, Switzerland). 2009;218(1):26–32.
Tan JK, Balagurusamy M, Fung K, et al. Effect of quality of life impact and clinical severity on adherence to topical acne treatment. J Cutan Med Surg. 2009;13:204–8.
Eichenfield LF, Nighland M, Rossi AB, et al. Phase 4 study to assess tretinoin pump for the treatment of facial acne. J Drugs Dermatol. 2008;7:1129–36.
Jones-Caballero M, Pedrosa E, Peñas PF. Self-reported adherence to treatment and quality of life in mild to moderate acne. Dermatology (Basel, Switzerland). 2008;217(4):309–14.
Baker M, Tuley M, Busdiecker FL, et al. Adapalene gel 0.1% is effective and well tolerated in acne patients in a dermatology practice setting. Cutis. 2001;68(4 Suppl.):41–7.
Mufleh L, Gonzalez M, Judodihardjo H, Finlay AY. Compliance is high in patients taking oral isotretinoin for acne. British J Dermatol. 1999;55(141):87.
Zaghloul SS, Cunliffe WJ, Goodfield MJ. Objective assessment of compliance with treatments in acne. Br J Dermatol. 2005;152(5):1015–21.
Flanders P, McNamara JR. Prediction of compliance with an over-the-counter acne medication. J Psychol. 1984;118(1ST Half):31–6.
Marazzi P, Boorman GC, Donald AE, et al. Clinical evaluation of double strength isotrexin versus benzamycin in the topical treatment of mild to moderate acne vulgaris. J Dermatol Treat. 2002;13:111–7.
Cunliffe WJ, Fernandez C, Bojar R, et al. An observer-blind parallel-group, randomized, multicentre clinical and microbiological study of a topical clindamycin/zinc gel and a topical clindamycin lotion in patients with mild/moderate acne. J Dermatol Treat. 2005;16:213–8.
Cook-Bolden F. Subject preferences for acne treatments containing adapalene gel 0.1%: results of the MORE trial. Cutis. 2006;78(1 Suppl.):26–33.
Yentzer BA, Alikhan A, Teuschler H, et al. An exploratory study of adherence to topical benzoyl peroxide in patients with acne vulgaris. J Am Acad Dermatol. 2009;60:879–80.
Tan X, Al-Dabagh A, Davis SA, Lin HC, Balkrishnan R, Chang J, Feldman SR. Medication adherence, healthcare costs and utilization associated with acne drugs in the Medicaid enrollees with acne vulgaris. Am J Clin Dermatol. 2013;14(3):243–51.
Yentzer BA, Gosnell AL, Clark AR, Pearce DJ, Balkrishnan R, Camacho FT, Young TA, Fountain JM, Fleischer AB Jr, Colón LE, Johnson LA, Preston N, Feldman SR. A randomized controlled pilot study of strategies to increase adherence in teenagers with acne vulgaris. J Am Acad Dermatol. 2011;64(4):793–5.
Feldman SR, Camacho FT, Krejci-Manwaring J, Carroll CL, Balkrishnan R. Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol. 2007;57(1):81–3 Epub 2007 May 10.
Heaton E, Levender MM, Feldman SR. Timing of office visits can be a powerful tool to improve adherence in the treatment of dermatologic conditions. J Dermatol Treat. 2013;24(2):82–8. doi: 10.3109/09546634.2011.588194. (Epub 2013 Feb 24. Review. PubMed PMID: 23432428).
Lott R, Taylor SL, O’Neill JL, Krowchuk DP, Feldman SR. Medication adherence among acne patients: a review. J Cosmet Dermatol. 2010;9(2):160–6.
Yentzer BA, Wood AA, Sagransky MJ, O’Neill JL, Clark AR, Williams LL, Feldman SR. An Internet-based survey and improvement of acne treatment outcomes. Arch Dermatol. 2011;147(10):1223–4.
Thiboutot D, Dreno B, Layton A. Acne counseling to improve adherence. Cutis. 2008;81(1):81–6.
Fenerty SD, West C, Davis SA, Kaplan SG, Feldman SR. The effect of reminder systems on patients’ adherence to treatment. Patient Prefer Adher. 2012;6:127–35.
Funding
The Center for Dermatology Research is supported by an unrestricted educational grant from Galderma Laboratories, L.P. Dr. Feldman is a consultant and speaker for Galderma, Stiefel/GlaxoSmithKline, Abbott Labs, Warner Chilcott, Janssen, Amgen, Photomedex, Genentech, BiogenIdec, and Bristol Myers Squibb. Dr. Feldman has received grants from Galderma, Astellas, Abbott Labs, Warner Chilcott, Janssen, Amgen, Photomedex, Genentech, BiogenIdec, Coria/Valeant, Pharmaderm, Ortho Pharmaceuticals, Aventis Pharmaceuticals, Roche Dermatology, 3M, Bristol Myers Squibb, Stiefel/GlaxoSmithKline, Novartis, Medicis, Leo, HanAll Pharmaceuticals, Celgene, Basilea, and Anacor and has received stock options from Photomedex. He is owner of www.DrScore.com and a founder of Causa Research. The other authors have no conflicts to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Snyder, S., Crandell, I., Davis, S.A. et al. Medical Adherence to Acne Therapy: A Systematic Review. Am J Clin Dermatol 15, 87–94 (2014). https://doi.org/10.1007/s40257-014-0063-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40257-014-0063-y